iXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases

Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses